IQGAP1 scaffold-MAP kinase interactions enhance multiple myeloma clonogenic growth and self-renewal

Christian Gocke, Ross McMillan, Qiuju Wang, Asma Begum, Vesselin R. Penchev, Syed Abbas Ali, Ivan M Borrello, Carol Ann Huff, William Matsui

Research output: Contribution to journalArticle

Abstract

Despite improved outcomes in newly diagnosed multiple myeloma, virtually all patients relapse and ultimately develop drug-resistant disease. Aberrant RAS/MAPK signaling is activated in the majority of relapsed/refractory multiple myeloma patients, but its biological consequences are not fully understood. Selfrenewal, as defined by the long-term maintenance of clonogenic growth, is essential for disease relapse, and we examined the role of RAS/MAPK activation on multiple myeloma self-renewal by targeting IQ motif-containing GTPase-activating protein 1 (IQGAP1), an intracellular scaffold protein required for mutant RAS signaling. We found that loss of IQGAP1 expression decreased MAPK signaling, cell-cycle progression, and tumor colony formation. Similarly, a peptide mimicking the WW domain of IQGAP1 that interacts with ERK inhibited the clonogenic growth and self-renewal of multiple myeloma cell lines and primary clinical specimens in vitro as well as tumor-initiating cell frequency in immunodeficient mice. During multiple myeloma progression, self-renewal may be enhanced by aberrant RAS/MAPK signaling and inhibited by targeting IQGAP1.

Original languageEnglish (US)
Pages (from-to)2733-27339
Number of pages24607
JournalMolecular Cancer Therapeutics
Volume15
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Multiple Myeloma
Phosphotransferases
Growth
Recurrence
Neoplastic Stem Cells
Mutant Proteins
Cell Cycle
IQ motif containing GTPase activating protein 1
Cell Line
Peptides
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

IQGAP1 scaffold-MAP kinase interactions enhance multiple myeloma clonogenic growth and self-renewal. / Gocke, Christian; McMillan, Ross; Wang, Qiuju; Begum, Asma; Penchev, Vesselin R.; Ali, Syed Abbas; Borrello, Ivan M; Huff, Carol Ann; Matsui, William.

In: Molecular Cancer Therapeutics, Vol. 15, No. 11, 01.11.2016, p. 2733-27339.

Research output: Contribution to journalArticle

@article{f8065f0a03ad4e9aa8fc88ec03aad5ed,
title = "IQGAP1 scaffold-MAP kinase interactions enhance multiple myeloma clonogenic growth and self-renewal",
abstract = "Despite improved outcomes in newly diagnosed multiple myeloma, virtually all patients relapse and ultimately develop drug-resistant disease. Aberrant RAS/MAPK signaling is activated in the majority of relapsed/refractory multiple myeloma patients, but its biological consequences are not fully understood. Selfrenewal, as defined by the long-term maintenance of clonogenic growth, is essential for disease relapse, and we examined the role of RAS/MAPK activation on multiple myeloma self-renewal by targeting IQ motif-containing GTPase-activating protein 1 (IQGAP1), an intracellular scaffold protein required for mutant RAS signaling. We found that loss of IQGAP1 expression decreased MAPK signaling, cell-cycle progression, and tumor colony formation. Similarly, a peptide mimicking the WW domain of IQGAP1 that interacts with ERK inhibited the clonogenic growth and self-renewal of multiple myeloma cell lines and primary clinical specimens in vitro as well as tumor-initiating cell frequency in immunodeficient mice. During multiple myeloma progression, self-renewal may be enhanced by aberrant RAS/MAPK signaling and inhibited by targeting IQGAP1.",
author = "Christian Gocke and Ross McMillan and Qiuju Wang and Asma Begum and Penchev, {Vesselin R.} and Ali, {Syed Abbas} and Borrello, {Ivan M} and Huff, {Carol Ann} and William Matsui",
year = "2016",
month = "11",
day = "1",
doi = "10.1158/1535-7163.MCT-16-0323",
language = "English (US)",
volume = "15",
pages = "2733--27339",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - IQGAP1 scaffold-MAP kinase interactions enhance multiple myeloma clonogenic growth and self-renewal

AU - Gocke, Christian

AU - McMillan, Ross

AU - Wang, Qiuju

AU - Begum, Asma

AU - Penchev, Vesselin R.

AU - Ali, Syed Abbas

AU - Borrello, Ivan M

AU - Huff, Carol Ann

AU - Matsui, William

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Despite improved outcomes in newly diagnosed multiple myeloma, virtually all patients relapse and ultimately develop drug-resistant disease. Aberrant RAS/MAPK signaling is activated in the majority of relapsed/refractory multiple myeloma patients, but its biological consequences are not fully understood. Selfrenewal, as defined by the long-term maintenance of clonogenic growth, is essential for disease relapse, and we examined the role of RAS/MAPK activation on multiple myeloma self-renewal by targeting IQ motif-containing GTPase-activating protein 1 (IQGAP1), an intracellular scaffold protein required for mutant RAS signaling. We found that loss of IQGAP1 expression decreased MAPK signaling, cell-cycle progression, and tumor colony formation. Similarly, a peptide mimicking the WW domain of IQGAP1 that interacts with ERK inhibited the clonogenic growth and self-renewal of multiple myeloma cell lines and primary clinical specimens in vitro as well as tumor-initiating cell frequency in immunodeficient mice. During multiple myeloma progression, self-renewal may be enhanced by aberrant RAS/MAPK signaling and inhibited by targeting IQGAP1.

AB - Despite improved outcomes in newly diagnosed multiple myeloma, virtually all patients relapse and ultimately develop drug-resistant disease. Aberrant RAS/MAPK signaling is activated in the majority of relapsed/refractory multiple myeloma patients, but its biological consequences are not fully understood. Selfrenewal, as defined by the long-term maintenance of clonogenic growth, is essential for disease relapse, and we examined the role of RAS/MAPK activation on multiple myeloma self-renewal by targeting IQ motif-containing GTPase-activating protein 1 (IQGAP1), an intracellular scaffold protein required for mutant RAS signaling. We found that loss of IQGAP1 expression decreased MAPK signaling, cell-cycle progression, and tumor colony formation. Similarly, a peptide mimicking the WW domain of IQGAP1 that interacts with ERK inhibited the clonogenic growth and self-renewal of multiple myeloma cell lines and primary clinical specimens in vitro as well as tumor-initiating cell frequency in immunodeficient mice. During multiple myeloma progression, self-renewal may be enhanced by aberrant RAS/MAPK signaling and inhibited by targeting IQGAP1.

UR - http://www.scopus.com/inward/record.url?scp=84995421887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995421887&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-16-0323

DO - 10.1158/1535-7163.MCT-16-0323

M3 - Article

C2 - 27573425

AN - SCOPUS:84995421887

VL - 15

SP - 2733

EP - 27339

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 11

ER -